2000
DOI: 10.1212/wnl.55.10.1588
|View full text |Cite
|
Sign up to set email alerts
|

Acetazolamide treatment for migraine aura status

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
31
0
2

Year Published

2002
2002
2015
2015

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 53 publications
(34 citation statements)
references
References 6 publications
1
31
0
2
Order By: Relevance
“…Acetazolamide has been reported to be effective in case reports of familial hemiplegic migraine with or without ataxia, 105 episodic ataxia type 2, 106,107 spinocerebellar ataxia type 2, 108 and migraine aura status. 109 Two recent case reports suggest that acetazolamide may be beneficial in CADASIL, and we have recently demonstrated improvement in cerebral perfusion on SPECT in a CADASIL patient following administration of oral acetazolamide. 110 -113 Given the propensity for cardiovascular and cerebrovascular complications, minimizing vascular risk factors and implementing therapy for primary or secondary prevention of stroke and myocardial infarction seems prudent.…”
Section: Treatmentmentioning
confidence: 68%
“…Acetazolamide has been reported to be effective in case reports of familial hemiplegic migraine with or without ataxia, 105 episodic ataxia type 2, 106,107 spinocerebellar ataxia type 2, 108 and migraine aura status. 109 Two recent case reports suggest that acetazolamide may be beneficial in CADASIL, and we have recently demonstrated improvement in cerebral perfusion on SPECT in a CADASIL patient following administration of oral acetazolamide. 110 -113 Given the propensity for cardiovascular and cerebrovascular complications, minimizing vascular risk factors and implementing therapy for primary or secondary prevention of stroke and myocardial infarction seems prudent.…”
Section: Treatmentmentioning
confidence: 68%
“…Triptans failed to shorten the duration of aura and should be avoided in older patients who have vascular risk factors (168,175,176). Intranasal ketamine (177,178), acetazolamide (179), intravenous furosemide (180), and lamotrigine (181)(182)(183)(184) have been reported as effective in persistent migraine aura and status migrainous patients.…”
Section: Acute Treatmentmentioning
confidence: 99%
“…56 Persistent migraine aura without headache have been effectively treated with acetazolamide and valproic acid. 57,58 …”
Section: Diagnosis and Treatmentmentioning
confidence: 99%